Chin Augmentation With Hyaluronic Acid: An Injection Technique Based on Anatomical Morphology.
Abstract
[BACKGROUND] Chin augmentation with hyaluronic acid (HA) injections can effectively improve mental appearance.
[OBJECTIVE] To introduce a HA injection technique for chin augmentation and evaluate its clinical effects.
[METHODS] A total of 326 patients who received HA injection for chin augmentation from January 2018 to May 2021 were retrospectively reviewed. All patients were injected with the technique according to the anatomical morphology of the chin using a needle and cannula. Patient data were collected, the effects were analyzed, and adverse reactions were observed and recorded.
[RESULTS] There were 326 patients involved in this study with a mean age of 26.4 years. The median volume of HA injected was 1.85 mL. The shape and contour of the chin was significantly improved in all patients immediately after injection. Most improvements were retained up to 6 months and partial improvements remained visible for 12 months. Swelling and pain occurred in 284 patients (87.1%), local ecchymosis occurred in 31 patients (9.5%), and asymmetry was found in 8 patients (2.5%). There were no other complications such as infection, embolism, necrosis, nodule, or witch's chin. All patients reported satisfaction with results of the HA injections.
[CONCLUSION] Injection of HA according to the anatomical morphology of the chin is a safe and effective technique for chin augmentation and results in high patient satisfaction.
[OBJECTIVE] To introduce a HA injection technique for chin augmentation and evaluate its clinical effects.
[METHODS] A total of 326 patients who received HA injection for chin augmentation from January 2018 to May 2021 were retrospectively reviewed. All patients were injected with the technique according to the anatomical morphology of the chin using a needle and cannula. Patient data were collected, the effects were analyzed, and adverse reactions were observed and recorded.
[RESULTS] There were 326 patients involved in this study with a mean age of 26.4 years. The median volume of HA injected was 1.85 mL. The shape and contour of the chin was significantly improved in all patients immediately after injection. Most improvements were retained up to 6 months and partial improvements remained visible for 12 months. Swelling and pain occurred in 284 patients (87.1%), local ecchymosis occurred in 31 patients (9.5%), and asymmetry was found in 8 patients (2.5%). There were no other complications such as infection, embolism, necrosis, nodule, or witch's chin. All patients reported satisfaction with results of the HA injections.
[CONCLUSION] Injection of HA according to the anatomical morphology of the chin is a safe and effective technique for chin augmentation and results in high patient satisfaction.
추출된 의학 개체 (NER)
| 유형 | 영어 표현 | 한국어 / 풀이 | UMLS CUI | 출처 | 등장 |
|---|---|---|---|---|---|
| 재료 | ha
|
히알루론산 | dict | 6 | |
| 시술 | chin augmentation
|
턱끝성형술 | dict | 5 | |
| 재료 | hyaluronic acid
|
히알루론산 | dict | 2 | |
| 해부 | chin
|
scispacy | 1 | ||
| 합병증 | infection
|
감염 | dict | 1 | |
| 합병증 | necrosis
|
괴사 | dict | 1 | |
| 합병증 | asymmetry
|
비대칭 | dict | 1 | |
| 약물 | 326
|
C5191353
326
|
scispacy | 1 | |
| 약물 | [BACKGROUND] Chin
|
scispacy | 1 | ||
| 약물 | [OBJECTIVE]
|
scispacy | 1 | ||
| 질환 | pain
|
C0030193
Pain
|
scispacy | 1 | |
| 질환 | ecchymosis
|
C0013491
Ecchymosis
|
scispacy | 1 | |
| 질환 | embolism
|
C0013922
Embolism
|
scispacy | 1 | |
| 기타 | patients
|
scispacy | 1 | ||
| 기타 | Patient
|
scispacy | 1 |
MeSH Terms
Adult; Chin; Cosmetic Techniques; Humans; Hyaluronic Acid; Injections; Patient Satisfaction; Retrospective Studies
📑 인용 관계
🔗 함께 등장하는 도메인
이 논문이 속한 카테고리와 같은 논문에서 자주 함께 다뤄지는 카테고리들
관련 논문
- Penetrating globe injury following periocular hyaluronic acid filler injection: A case report.
- Choroidal ischemia after self-injection of hyaluronic acid filler.
- Epidermal inclusion cyst after breast reduction mammoplasty.
- Intra-articular therapies for synovial joint dysfunction: a comprehensive integrative review.
- Clinical safety of a low-modification hyaluronic acid filler (MoD 2%) for facial rejuvenation.